Histology in 3D
New staining method enables Nano-CT imaging of tissue samples
To date, examining patient tissue samples has meant cutting them into thin slices for histological analysis. This might now be set to change – thanks to a new staining method devised by an interdisciplinary team from the Technical University of Munich (TUM). This allows specialists to investigate three-dimensional tissue samples using the Nano-CT system also recently developed at TUM.
These images were created using the new staining method: left: Micro-CT image of a mouse kidney, right: Nano-CT image of the same tissue.
Müller, Pfeiffer / TUM / reproduced with permission from PNAS)
Chemist Dr. Madleen Busse has started from a standard staining procedure to develop a staining method suited for CT.
Heddergott / TUM
Tissue sectioning is a routine procedure in hospitals, for instance to investigate tumors. As the name implies, it entails cutting samples of body tissue into thin slices, then staining them and examining them under a microscope. Medical professionals have long dreamt of the possibility of examining the entire, three-dimensional tissue sample and not just the individual slices. The most obvious way forward here lies in computed tomography (CT) scanning – also a standard method used in everyday clinical workflows.
Previous limitations in resolution and contrast
Thus far, there have been two major hurdles to the realization of this goal. Firstly, the resolution of conventional CT scanners is too low. Today’s Micro- and Nano-CT systems are rarely suitable for use in frontline medicine. Some do not offer sufficiently high resolution, while others rely on radiation from large particle accelerators.
Secondly, soft tissue is notoriously difficult to examine using CT equipment. Samples have to be stained to render them visible in the first place. Stains for CT scanning are sometimes highly toxic, and they are also extremely time-consuming to apply. At times they modify the tissue to such an extent that further analysis is then impossible.
Successful collaboration between physics, chemistry and medicine
Now, however, scientists at TUM’s Munich School of BioEngineering (MSB) have solved both problems. In November 2017, Prof. Franz Pfeiffer and his team unveiled a Nano-CT system that delivers resolutions of up to 100 nanometers and is suitable for use in typical laboratory settings. In the current issue of the scientific journal PNAS, the cross-disciplinary research team from physics, chemistry and medicine also presents a staining method for histological examination with Nano-CT.
Using a mouse kidney, the scientists have successfully demonstrated that Nano-CT is able to generate 3D images that match the information granularity of tissue sections. At the core of the staining method lies eosin, a standard dye used in tissue sampling that was previously considered unsuitable for CT.
“Our approach included developing a special pre-treatment so that we can use eosin anyway,” outlines chemist Dr. Madleen Busse. The staining method is so time-efficient that it is also suited to everyday clinical workflows. “Another important benefit is that there are no problems using established methods to examine the tissue sample following the scan,” adds Busse.
Enhancement rather than replacement
In the next step, the researchers are looking to examine human tissue samples. However, CT histology is not set to replace conventional methods any time soon. For the moment, at least, the team views the new procedure as supplementary – for instance giving doctors additional insights into the three-dimensional distribution of cells and nuclei. Franz Pfeiffer also sees new opportunities here for basic medical research: “Alongside diagnostic applications, the non-destructive 3D examination enabled by Nano-CT could deliver new insights into the microscopic origins of widespread diseases such as cancer.”
Original publication
Other news from the department science
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
WITec establishes new office in China
Enduring cold temperatures alters fat cell epigenetics
Caltech chemists say antibody surrogates are just a 'click' away
Thermo Fisher Scientific and Intrinsic Bioprobes Announce Alliance in Mass Spectrometric Immunoassay (MSIA) Workflow Development
Water distribution in the fuel cell made visible in 4D - The analysis opens new possibilities for more efficient and thus more cost-effective fuel cells
Which animals exist right here? Now researchers are able to find the answer out of thin air - Researchers have found a way to collect samples of animal DNA from the air with a new method
A new era of genome sequencing - 16 new high-quality reference genomes from vertebrates
Amorfix detects vCJD prions in blood from non-human primates
CRELUX and ProQinase establish joint crystal-grade kinase protein and structures platform
Takara Bio and Eppendorf cooperate - Automation of Takara Bio’s Chemistries on Eppendorf’s Automated Pipetting Systems for Significantly Higher Efficiency
University of Leicester researchers discover new fluorescent silicon nanoparticles - Research may ultimately track the uptake of drugs by the body's cells